perindopril and Auricular Fibrillation
perindopril has been researched along with Auricular Fibrillation in 15 studies
Research
Studies (15)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (73.33) | 29.6817 |
2010's | 4 (26.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Akçay, M; Aslan, AN; Baştuğ, S; Bozkurt, E; Durmaz, T; Sari, C; Sari, SÖ | 1 |
Dong, F; Li, H; Qiu, Y; Shang, Y; Wang, Q; Wang, Z; Zheng, L; Zhou, D | 1 |
Abadir, E; Chalmers, J; Cooper, M; de Galan, B; Du, X; Hamet, P; Harrap, S; Lip, GY; Ninomiya, T; Patel, A; Pillai, A; Poulter, N; Woodward, M | 1 |
Fak, AS; Ozben, B; Papila-Topal, N; Sumerkan, M; Tanrikulu, AM; Toprak, A | 1 |
DU, X; Lei, T; Liu, XH; Liu, XP; Luo, TY; Shi, JH; Wang, HY | 1 |
Kanorskaia, IuS; Kanorskiĭ, SG | 1 |
Kanorskiĭ, SG; Shevelev, VI | 1 |
Anderson, C; Arima, H; Chalmers, J; Colman, S; Hart, RG; MacMahon, S; Neal, B; Rodgers, A; Woodward, M | 1 |
Dai, Y; Lan, XB; Ling, ZY; Liu, ZC; Luo, KL; Su, L; Wu, JJ; Yang, XY; Yin, YH | 1 |
Dai, Y; Dalal, D; Dong, J; Lan, X; Ling, Z; Liu, D; Liu, Z; Luo, K; She, Q; Su, L; Woo, K; Wu, J; Yin, Y | 1 |
Li, G; Liu, T | 1 |
Gopalam, M; Kanna, B | 1 |
Georgescu, CA; Grecu, M; Olteanu, RO; Olteanu, SS | 1 |
Bodrikova, VV; Kanorskaia, IuS; Kanorskiĭ, SG | 1 |
Abuladze, GV; Dzhincharadze, BZ; Dzhindzholiia, NR; Kadzhaia, TZ; Narsiia, EV | 1 |
Trials
7 trial(s) available for perindopril and Auricular Fibrillation
Article | Year |
---|---|
Perindopril for the prevention of atrial fibrillation recurrence after radiofrequency catheter ablation: One-year experience.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Catheter Ablation; Echocardiography; Female; Humans; Male; Middle Aged; Perindopril; Postoperative Complications; Pulmonary Veins; Secondary Prevention; Treatment Outcome | 2016 |
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.
Topics: Aged; Antihypertensive Agents; Atrial Fibrillation; Blood Glucose; Confidence Intervals; Diabetic Angiopathies; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Risk Factors; Treatment Outcome | 2009 |
Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Atrial Fibrillation; Blood Pressure; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Hypertension; Indapamide; Ischemic Attack, Transient; Male; Middle Aged; Perindopril; Placebos; Risk; Stroke; Time Factors; Treatment Outcome | 2005 |
[Long-term clinical efficacy of losartan or perindopril combination therapy with low-dose amiodarone in patients with paroxysmal atrial fibrillation].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Losartan; Male; Middle Aged; Perindopril; Prospective Studies | 2006 |
Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Drug Therapy, Combination; Female; Heart Atria; Humans; Losartan; Male; Middle Aged; Perindopril; Prospective Studies; Secondary Prevention; Treatment Outcome | 2006 |
Does treatment with ACE inhibitors prevent the long term recurrences of lone atrial fibrillation after cardioversion?
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, Combination; Electric Countershock; Female; Follow-Up Studies; Humans; Male; Middle Aged; Perindopril; Propafenone; Secondary Prevention; Time Factors | 2007 |
[Influence of perindopril, rosuvastatin, or omega-3 polyunsaturated fatty acids on efficacy of antirecurrence therapy with sotalol in patients with persistent atrial fibrillation].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Fatty Acids, Omega-3; Female; Fluorobenzenes; Follow-Up Studies; Heart Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Perindopril; Pyrimidines; Rosuvastatin Calcium; Secondary Prevention; Sotalol; Sulfonamides; Treatment Outcome | 2007 |
Other Studies
8 other study(ies) available for perindopril and Auricular Fibrillation
Article | Year |
---|---|
Severe jaundice due to intrahepatic cholestasis after initiating anticoagulation with rivaroxaban.
Topics: Aged; Anticoagulants; Antihypertensive Agents; Atrial Fibrillation; Carbazoles; Carvedilol; Cholestasis, Intrahepatic; Humans; Hypertension; Jaundice; Liver; Male; Perindopril; Propanolamines; Rivaroxaban; Severity of Illness Index; Treatment Outcome | 2016 |
Perindopril decreases P wave dispersion in patients with stage 1 hypertension.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Echocardiography; Humans; Hypertension; Male; Middle Aged; Perindopril | 2009 |
[Effects of perindopril and spirolactone on plasma aldosterone and left atrial remodeling in a canine model of atrial fibrillation].
Topics: Aldosterone; Animals; Atrial Fibrillation; Atrial Function; Disease Models, Animal; Dogs; Male; Mineralocorticoid Receptor Antagonists; Perindopril; Spironolactone | 2009 |
[Atrial fibrillation in patients with type 2 diabetes mellitus: specific features of development and antirecurrence therapy].
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Atrial Fibrillation; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Diabetic Neuropathies; Drug Monitoring; Female; Heart Conduction System; Heart Failure, Diastolic; Humans; Male; Middle Aged; Perindopril; Random Allocation; Secondary Prevention; Sotalol; Thioctic Acid; Treatment Outcome; Ventricular Dysfunction, Left | 2010 |
[Antihypertensive therapy and dynamics of vascular wall rigidity in elderly patients with non-valvular atrial fibrillation].
Topics: Aged; Ankle Brachial Index; Anticholesteremic Agents; Antihypertensive Agents; Arterial Pressure; Arteries; Atrial Fibrillation; Combined Modality Therapy; Drug Monitoring; Female; Fluorobenzenes; Humans; Hypertension; Male; Myocardial Infarction; Perindopril; Pulse Wave Analysis; Pyrimidines; Rosuvastatin Calcium; Stroke; Sulfonamides; Tetrazoles; Treatment Outcome; Ultrasonography, Doppler, Duplex; Valine; Valsartan; Vascular Resistance | 2012 |
Anti-inflammatory effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Potential benefits for the prevention of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Combinations; Humans; Losartan; Perindopril; Randomized Controlled Trials as Topic | 2006 |
Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, Combination; Humans; Losartan; Perindopril; Prospective Studies; Randomized Controlled Trials as Topic; Secondary Prevention | 2007 |
[The therapeutic efficiency of complex-ACE inhibitor (perindopril) and traditional antiarrhythmic-treatment for prevention atrial fibrillation paroxysms after successful electric cardio version].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Electric Countershock; Female; Humans; Male; Middle Aged; Perindopril; Treatment Outcome | 2008 |